Tessera Therapeutics

Cambridge, United States

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Mar 2026

Grant

Biopharma Biotechnology Genetics Life Science Therapeutics

Top Investors

Bill & Melinda Gates Foundation Cormorant Asset Management Qatar Investment Authority SoftBank Vision Fund Artis Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tessera Therapeutics

Who are Tessera Therapeutics's investors?

Tessera Therapeutics's investors include Bill & Melinda Gates Foundation, Cormorant Asset Management, Qatar Investment Authority, SoftBank Vision Fund, Artis Ventures.

Where is Tessera Therapeutics headquartered?

Tessera Therapeutics is headquartered in Cambridge, United States.

What does Tessera Therapeutics do?

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

What stage is Tessera Therapeutics at?

Tessera Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 23, 2026.

MLA

"Tessera Therapeutics — Funding & Investors." VCBacked, March 23, 2026, https://www.vcbacked.co/company/tessera-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Tessera Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tessera-therapeutics

Wikipedia (cite web)

{{cite web |title=Tessera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tessera-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 23, 2026.